首页 | 官方网站   微博 | 高级检索  
相似文献
 共查询到19条相似文献,搜索用时 62 毫秒
1.
目的 了解深圳市人民医院临床泌尿系感染标本中产ESBLs大肠埃希菌的基因型特点.方法 收集近几年深圳市人民医院临床尿液标本中非重复的产ESBLs大肠埃希菌43株,PCR分别扩增菌株的TEM、SHV、CTX-M基因,阳性株进行DNA测序分型.结果 43株产ESBLs大肠埃希菌中40株CTX-M基因阳性,分别为CTX-M-14型36株,CTX-M-9型2株,CTX-M-15型2株,其中17株CTX-M-14型菌株检出TEM-1基因;所有菌株均未检出SHV基因.结论 本地区致泌尿系感染产ESBLs大肠埃希菌中,CTX-M-14型为主.  相似文献   

2.
目的 了解深圳市人民医院产超广谱β-内酰胺酶(ESBLs)大肠埃希菌合并产AmpC酶的状况及基因型特点.方法 从近几年深圳市人民医院产ESBLs大肠埃希菌临床菌株中,筛选出对头孢西丁耐药菌株51株,PCR分别扩增菌株的TEM、SHV、CTX-M基因,同时应用多重PCR检测菌株的AmpC酶基因,序列测定PCR阳性产物以确定其基因亚型.结果 51株菌中有49株至少检出一种ESBLs或AmpC基因.单ESBLs基因阳性菌株37株(72.5%),单AmpC基因阳性4株(7.8%),合并ESBLs和AmpC基因阳性的8株(15.6%).共有41株(80.4%)含CTX-M-14基因,4株含CTX-M-15,其他基因型ESBLs较少.2株检出两种ESBLs基因;一株同时检三种ESBLs基因.检出AmpC基因的菌株12株,其中10株为DHA-1型,2株为CMY-2型;其中6株DHA-1型及2株CMY-2型菌同时检出CTX-M-14基因.结论 该院头孢西丁耐药产ESBLs大肠埃希菌中大多数为单产ESBLs菌,主要为CTX-M-14型;少数同时产生ESBLs和AmpC酶,AmpC酶以DHA-1型为最常见.  相似文献   

3.
目的 了解新生儿病区产ESBLs大肠埃希菌整合子的携带情况及其耐药性.方法 采用K-B琼脂扩散法对56株产ESBLs大肠埃希菌进行药敏试验;应用PCR法检测Ⅰ类、Ⅱ类和Ⅲ类整合子;以肠杆菌科重复序列-聚合酶链式反应(ERIC-PCR)进行基因分型.结果 56株产ESBLs大肠埃希菌的Ⅰ类整合子检出率为60.7%,未检出Ⅱ类和Ⅲ类整合子;菌株对庆大霉素、环丙沙星、左氧氟沙星、复方新诺明、头孢唑林、氨曲南、头孢他啶的耐药率差异有统计学意义(P<0.05),阳性菌株的耐药率高于阴性菌株;56株大肠埃希菌分为45种基因型.结论 Ⅰ类整合子广泛存在于新生儿病区产ESBLs大肠埃希菌并与其耐药性相关.  相似文献   

4.
目的了解广东省中医院产超广谱β-内酰胺酶(ESBLs)的大肠埃希菌、肺炎克雷伯菌的流行、耐药特点和基因型分布。方法对该院2001年7月至2003年8月间临床分离保存的208株大肠埃希菌和肺炎克雷伯菌,用VITEK-32细菌鉴定仪进行细菌鉴定,用K—B法进行药敏试验,用双纸片法进行ESBLs初筛,用NCCLS1999年推荐的确证方法进行ESBLs确证。并采用PCR扩增和PCR产物测序方法对产ESBLs菌株进行基因分型。结果分离到产ESBLs细菌76株,总检出率为36.5%,其中肺炎克雷伯菌阳性率为41.9%(39/93)、大肠埃希菌阳性率为32.2%(37/115),产酶株的耐药率明显高于非产酶株,产ESBLs细菌对青霉素类、环丙沙星及头孢菌素类耐药率较高,加酶抑制剂克拉维酸或他唑巴坦后耐药率有明显下降;PCR初步分型结果表明:TEM型42株(55.3%),均为TEM-1型,CTX-M型27株(35.5%),SHV型33株(43.4%)。结论产ESBLs细菌具有多重耐药的特点;CTX-M型和SHV型是该院产ESBLs大肠埃希菌和肺炎克雷伯菌中流行的基因型。  相似文献   

5.
目的 了解深圳市人民医院致血流感染大肠埃希菌和肺炎克雷伯菌超广谱β-内酰胺酶(ESBLs)的检出率及基因型特点.方法 收集来自临床血液培养标本中的大肠埃希菌和肺炎克雷伯菌115株,采用ESBLs表型确证试验检测菌株的ESBLs,应用PCR扩增产ESBLs菌株TEM、SHV和CTX-M基因,并对阳性扩增产物进行DNA测序分型.结果 115株菌中共检出ESBLs阳性38株,检出率为33.0%;其中大肠埃希菌阳性25株,肺炎克雷伯菌阳性13株.25株产酶肠埃希菌中18株检出CTX-M-14基因,3株检出CTX-M-9基因.13株产酶肺炎克雷伯菌均检出SHV型基因,其中SHV-12阳性10株,SHV-2阳性2株,SHV-59阳性1株;该13株产酶菌中10株同时被检出含CTX-M-14或CTX-M-13基因.结论 该院致血流感染大肠埃希菌产ES-BLs以CTX-M-14为最主要基因型,肺炎克雷伯产ESBLs最常见为SHV-12和CTX-M-14型.  相似文献   

6.
由细菌超广谱β-内酰胺酶(ESBLs)引起的细菌耐药性一直是临床相关感染性疾病治疗中的棘手问题。从不同病区患者标本中分离了96株大肠埃希菌和80株肺炎克雷伯菌,分剐采用双纸片协同试验和药物敏感试验检测了上述菌株产生ESBLs情况及对17种抗生素的耐药性。结果发现,27.1%(26/96)的大肠埃希菌株和22.5%(18/80)肺炎克雷伯菌株产ESBLs。ICU病房分离的大肠埃希菌和肺炎克雷伯菌株ESBLs总阳性率(46.0%)与介入科病房和烧伤科病房分离菌株ESBLs总阳性率(28.6%和25.0%)无显著性差异(P〉0.05),但明显高于呼吸科、骨科、其他病房及门诊部分离菌株ESBLs总阳性率(6.3%~14.3%,P〈0.01)。不产ESBLs大肠埃希菌株和肺炎克雷伯菌株对17种抗生素耐药率明显低于产ESBLs菌株。产ESBLs大肠埃希菌和肺炎克雷伯菌对氨曲南均敏感,对氨苄西林/舒巴坦、阿莫西林/棒酸、阿米卡星耐药率仅为15.8%-23.4%。上述实验结果提示,大肠埃希菌和肺炎克雷伯菌临床菌株中有较高的ESBLs阳性率,不同病区患者感染的大肠埃希菌和肺炎克雷伯菌ESBLs阳性率有很大差异,氨曲南、氨苄西林/舒巴坦、阿莫西林/棒酸、阿米卡星可作为治疗产ESBLs大肠埃希菌和肺炎克雷伯菌感染性疾病的首选药物。  相似文献   

7.
了解临床分离的产ESBLs大肠埃希菌(ESBLs-producing Escherichia coli,ESBL-EC)中Ⅰ、Ⅱ、Ⅲ类整合子及ESBL-EC基因型的分布。收集2014年1月至12月某三甲医院住院患者分离的大肠埃希菌,经全自动细菌分析系统鉴定并检测其对临床常用抗菌药物的耐药性,双纸片协同试验确定ESBL-EC,采用聚合酶链反应(PCR)对整合子基因和ESBLs基因进行检测。K-B法比较整合子阳性菌株与阴性菌株的耐药率。结果发现,98株临床非重复ESBL-EC对青霉素类、头孢菌素类、喹诺酮类、单环酰胺类和庆大霉素耐药率均大于50%,对妥布霉素耐药率为31.62%,对呋喃妥因、阿莫西林/克拉维酸和阿米卡星较敏感,分别为11.11%、13.4%和6.12%;对碳青霉烯类抗菌素、替加环素和哌拉西林/他唑巴坦敏感率为100%。98株菌中检出47株含Ⅰ类整合子(47.96%),3株含Ⅱ类整合子(3.06%),所有菌株中有1株同时含Ⅰ类和Ⅱ类整合子,未检出Ⅲ类整合子。整合子阳性菌株对四环素和复方新诺明的耐药率高于整合子阴性菌株(P0.05)。98株菌中β-内酰胺酶基因TEM、CTX-M-9、CTX-M-1、CTX-M-2和SHV阳性率分别为62.24%、53.06%、32.65%、4.08%和3.06%,ESBL-EC基因分型分布以TEM合并CTX-M-9型(共30株)最多见,占30.61%。结果表明,Ⅰ类整合子在产ESBLs大肠埃希菌中分布广泛,本研究尚不足以证明整合子的存在可影响ESBL-EC菌株抗生素耐药水平。同时携带TEM和CTX-M-9基因是安徽医科大学解放军174临床学院产ESBLs大肠埃希菌临床耐药菌株产生的主要原因。  相似文献   

8.
产超广谱β-内酰胺酶大肠埃希菌的耐药性分析   总被引:5,自引:0,他引:5  
目的了解杭州市第一人民医院产ESBLs大肠埃希菌的发生比例及对临床上常用的24种抗菌药物的耐药率变化.方法收集2003 2004年该院各类临床标本中分离的大肠埃希菌,采用NCCLS推荐的表型确证试验方法检测ESBLs菌株;药敏试验采用纸片扩散法.结果2003年与2004年,产ESBLs的大肠埃希菌分离率分别为46.11%(184/399)、57.44%(386/672)(P=0.0003);2年来,ESBLs阳性菌对临床常用的24种药物表现出较高的耐药性,耐药率上升非常显著(P=0.0005);非产ESBLs大肠埃希菌对大多数抗菌药物仍保持较高的敏感率;但2004年ESBLs阴性的大肠埃希菌的耐药性,比2003年显著上升(χ^2=37.785,P=0.0005).结论尽早开展产ESBLs菌的监测,合理使用抗菌药物,对于有效控制产ESBLs菌的播散与流行是一项重要措施.  相似文献   

9.
目的 了解产超广谱β-内酰胺酶(ESBLs)大肠埃希菌(ECO)和肺炎克雷伯菌(KPN)的临床分布及耐药性,为临床合理用药提供依据.方法 采用VITEK-2全自动微生物鉴定/药敏分析系统对细菌进行菌株鉴定及药敏分析,对产ESBLs的ECO和KPN的临床分布与耐药结果用WHONET 5.4软件进行统计分析,应用SPSS 11.5软件进行卡方检验.结果 1955株菌中共检出产ESBLs菌916株,检出率为46.9%,其中EC0 570株,检出率为58.9%,KPN 346株,检出率为35.0%,产ESBLs菌主要从痰液和尿液中检出,主要来自ICU、普外科和神经外科;产ESBLs菌对多种抗生素的耐药率明显高于非产ESBLs菌,差异有统计学意义(P<0.05),对哌拉西林/他唑巴坦、头孢替坦和亚胺培南较敏感.结论 产ESBLs菌株所致的感染以泌尿道感染和呼吸道感染为主,且呈多重耐药性,临床上要重视对产ESBLs菌株的检测和细菌耐药监测,有效控制产ESBLs菌株的产生和流行.  相似文献   

10.
中药抗耐药大肠埃希菌研究进展   总被引:1,自引:0,他引:1  
近年来,耐药大肠埃希菌感染日趋严重,产超广谱β-内酰胺酶的大肠埃希菌株不断增加,由于细菌的多重耐药性,西药抗生素治疗效果差.医药工作者将新药物研究的方向投向中药.本研究就近年来中药抗耐药大肠埃希菌研究进展进行综述.  相似文献   

11.
Site-specific insertion of gene cassettes into integrons   总被引:14,自引:3,他引:14  
Site-specific insertion of gene cassettes into the insert region of integrons has been demonstrated. Insertion was only observed if the integron DNA integrase was expressed in the recipient cell and if the cassette DNA was ligated prior to transformation. The essential ligation products were resistant to treatment with exonuclease III, indicating that they were closed circular molecules. Insertion of cassettes into integron fragments containing either no insert (one recombination site), or one gene cassette (two recombination sites), was demonstrated. In the latter case, insertion occurred predominantly at the core site located 5′ to the resident cassette, which corresponds to the only site available when no insert is present in the recipient. When DNA molecules including two gene cassettes were used, insertion of only one of the gene cassettes was generally observed, suggesting that resolution of the circular molecule to generate two independent circular cassettes occurred more rapidly than insertion into the recipient integron.  相似文献   

12.
In this study,326 Escherichia coli isolates from food animals collected during the last four decades in China were characterized using antimicrobial susceptibility testing and screening for integrons/cassettes.Minimum inhibitory concentration(MIC) testing indicated that the antimicrobial resistance of E.coli has increased since the 1970s.The findings of this study present a warning to veterinary practitioners about the excessive use of antimicrobials,and suggest the necessity for surveillance and control of antimicrobial resistance in veterinary clinical medicine in China.  相似文献   

13.
目的了解I类整合子在产ESBLs和非产ESBLs大肠埃希菌中分布状况,分析I类整合子在细菌多重耐药中的作用。方法用PCR方法扩增I类整合酶基因,经电泳后检测扩增产物。用2χ检验进行统计学分析,P<0.05为差异有显著性。结果105株大肠埃希菌检出I类整合子46株,检出率为43.8%。I类整合子在产ESBLs菌的检出率为53.4%,明显高于非产ESBLs菌(31.9%),2χ检验,P<0.01。I类整合子阳性菌株多重耐药率为68.8%(33/48),明显高于阴性菌株(33.3%),P<0.05。I类整合子阳性菌株和产ESBLs菌均对青霉素类、喹诺酮类、磺胺类抗生素表现出较高的耐药率。所有菌株均对亚胺培南敏感。结论I类整合子携带与产ESBLs菌株耐药有关,I类整合子阳性菌株对多种抗生素的耐药率大于整合子阴性菌株。  相似文献   

14.
15.
One hundred and twenty clinical and commensal Escherichia coli strains isolated in Switzerland from humans and from companion and farm animals were analysed for the prevalence of integrons of classes 1, 2, and 3 and for the characterization of their gene cassettes. The relationships between integron carriage and host category, and between integron carriage and phylogenetic E. coli lineage were also analysed. Integrons were detected in 48 (40%) of the isolates and were thus widely disseminated in the human and animal E. coli strains considered. Moreover, the association between integron carriage and certain animal categories (farm animals) suggests that animals that are raised for economic purposes might be exposed to a major antibiotic pressure. Finally, our data confirm that E. coli commensal strains represent a significant source of antibiotic-resistant determinants.  相似文献   

16.
17.
Class 1 integrons carried by pathogens have acquired over 100 different gene cassettes encoding resistance to antimicrobial compounds, helping to generate a crisis in the management of infectious disease. It is presumed that these cassettes originated from environmental bacteria, but exchange of gene cassettes has surprisingly never been demonstrated outside laboratory or clinical contexts. We aimed to identify a natural environment where such exchanges might occur, and determine the phylogenetic range of participating integrons. Here we examine freshwater biofilms and show that families of cassettes conferring resistance to quaternary ammonium compounds ( qac ) are found on class 1 integrons identical to those from clinical contexts, on sequence variants of class 1 integrons only known from natural environments, and on other diverse classes of integrons only known from the chromosomes of soil and freshwater Proteobacteria . We conclude that gene cassettes might be readily shared between different integron classes found in environmental, commensal and pathogenic bacteria. This suggests that class 1 integrons in pathogens have access to a vast pool of gene cassettes, any of which could confer a phenotype of clinical relevance. Exploration of this resource might allow identification of resistance or virulence genes before they become part of multi-drug-resistant human pathogens.  相似文献   

18.
Three hydrogen-based membrane biofilm reactors (MBfR) biologically reduced nitrate and perchlorate in a synthetic ion-exchange (IX) brine. Inocula from different natural saline environments were employed to initiate the three MBfRs. Under high-salinity (3%) conditions, bioreduction of nitrate and perchlorate occurred simultaneously, and the three MBfRs from the different inocula exhibited similar removal fluxes for nitrate and perchlorate. Clone libraries were generated from samples of the biofilms in the three MBfRs and compared to those of their inocula. When H2 was the sole exogenous electron donor under high-salinity conditions, MBfR-driven community shifts were observed with a similar pattern regardless of inoculum. The following 16S rRNA gene phylogenetic analysis showed the presence of novel perchlorate-reducing bacteria in the salt-tolerant mBfR communities. These findings suggest that autohydrogenotrophic and high-salinity conditions provided strong selective pressure for novel perchlorate-reducing populations in the mBfRs. Electronic supplementary material  The online version of this article (doi:) contains supplementary material, which is available to authorized users.  相似文献   

19.
An integron is a genetic unit that includes the determinants of the components of a site-specific recombination system capable of capturing and mobilizing genes that are contained in mobile elements called gene cassettes. An integron also provides a promoter for expression of the cassette genes, and integrons thus act both as natural cloning systems and as expression vectors. The essential components of an integron are an int gene encoding a site-specific recombinase belonging to the integrase family, an adjacent site, attl, that is recognized by the integrase and is the receptor site for the cassettes, and a promoter suitably oriented for expression of the cassette-encoded genes. The cassettes are mobile elements that include a gene (most commonly an antibiotic-resistance gene) and an integrase-specific recombination site that is a member of a family of sites known as 59-base elements. Cassettes can exist either free in a circularized form or integrated at the attl site, and only when integrated is a cassette formally part of an integron. A single site-specific recombination event involving the integron-associated attl site and a cassette-associated 59-base element leads to insertion of a free circular cassette into a recipient integron. Multiple cassette insertions can occur, and integrons containing several cassettes have been found in the wild. The integrase also catalyses excisive recombination events that can lead to loss of cassettes from an integron and generate free circular cassettes. Due to their ability to acquire new genes, integrons have a clear role in the evolution of the genomes of the plasmids and transposons that contain them. However, a more general role in evolution is also likely. Events involving recombination between a specific 59-base-element site and a nonspecific secondary site have recently been shown to occur. Such events should lead either to the insertion of cassettes at non-specific sites or to the formation of stable cointegrates between different plasmid molecules, and a cassette situated outside the integron context has recently been identified.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号